×
About 520 results

ALLMedicine™ Ventilator Management Center

Research & Reviews  162 results

Generating Evidence in ECMO Ventilation Strategies
https://clinicaltrials.gov/ct2/show/NCT05708365

Feb 1st, 2023 - This is a pilot, open label, pragmatic cluster-crossover clinical trial testing the feasibility and exploring the clinical impact of ICU-level ventilator management protocols as interventions in patients with acute respiratory failure requiring su...

Evaluation of Clinical Tool to Improve Adherence to Ventilator Management at UM
https://clinicaltrials.gov/ct2/show/NCT05661695

Dec 22nd, 2022 - Background: Respiratory Therapists (RTs) face challenges to provide high quality patient care including maintaining compliance with evidence-based practice protocols using lung protective ventilation (LPV) (tidal volume [VT] 4 to 8 ml predicted bo...

Successful treatment of invasive tracheobronchial pulmonary aspergillosis with venoveno...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764550
Journal of Medical Case Reports; Sato S, Kamata W et. al.

Dec 20th, 2022 - Invasive pulmonary Aspergillus and invasive bronchial aspergillosis is a life-threatening opportunistic fungal infection that predominantly affects immunocompromised hosts. A case series and review found that the mortality rate of invasive bronchi...

Add-on Reparixin in Adult Patients With ARDS
https://clinicaltrials.gov/ct2/show/NCT05496868

Dec 20th, 2022 - Phase 2, randomized, double-blinded, placebo controlled, multicenter study. All patients will receive therapy in line with current standard-of-care as it pertains to ARDS management (protocolized ventilator management will be made available to all...

Evaluation of Clinical Tool to Improve Adherence to Ventilator Management
https://clinicaltrials.gov/ct2/show/NCT05626699

Nov 25th, 2022 - Background: Respiratory Therapists (RTs) face challenges to provide high quality patient care including maintaining compliance with evidence-based practice protocols using lung protective ventilation (LPV) (tidal volume [VT] 4 to 8 ml predicted bo...

see more →

Clinicaltrials.gov  30 results

Generating Evidence in ECMO Ventilation Strategies
https://clinicaltrials.gov/ct2/show/NCT05708365

Feb 1st, 2023 - This is a pilot, open label, pragmatic cluster-crossover clinical trial testing the feasibility and exploring the clinical impact of ICU-level ventilator management protocols as interventions in patients with acute respiratory failure requiring su...

Evaluation of Clinical Tool to Improve Adherence to Ventilator Management at UM
https://clinicaltrials.gov/ct2/show/NCT05661695

Dec 22nd, 2022 - Background: Respiratory Therapists (RTs) face challenges to provide high quality patient care including maintaining compliance with evidence-based practice protocols using lung protective ventilation (LPV) (tidal volume [VT] 4 to 8 ml predicted bo...

Add-on Reparixin in Adult Patients With ARDS
https://clinicaltrials.gov/ct2/show/NCT05496868

Dec 20th, 2022 - Phase 2, randomized, double-blinded, placebo controlled, multicenter study. All patients will receive therapy in line with current standard-of-care as it pertains to ARDS management (protocolized ventilator management will be made available to all...

Evaluation of Clinical Tool to Improve Adherence to Ventilator Management
https://clinicaltrials.gov/ct2/show/NCT05626699

Nov 25th, 2022 - Background: Respiratory Therapists (RTs) face challenges to provide high quality patient care including maintaining compliance with evidence-based practice protocols using lung protective ventilation (LPV) (tidal volume [VT] 4 to 8 ml predicted bo...

Trial of Therapeutic Hypothermia in Patients With ARDS
https://clinicaltrials.gov/ct2/show/NCT04545424

Oct 10th, 2022 - Brief summary: Acute Respiratory Distress Syndrome (ARDS) is a serious condition that occurs as a complication of medical and surgical diseases, has a mortality of ~40%, and has no known treatment other than optimization of support. Data from basi...

see more →

News  16 results

Largest-to-Date COVID Mortality Study Released
https://www.medpagetoday.com/infectiousdisease/covid19/89613

Nov 11th, 2020 - Following news that the Pfizer and BioNTech COVID-19 vaccine achieved "more than 90%" efficacy in an interim analysis, the world is starting to focus on the limited initial supplies of COVID vaccines. A new medRxiv preprint looks at over 500,000 M...

What We Know About This New Deadly Enemy
https://www.medpagetoday.com/infectiousdisease/covid19/86774

May 29th, 2020 - With the U.S. recently passing the milestone of 100,000 deaths from COVID-19, MedPage Today Editor-in-Chief Martin Makary, MD, of Johns Hopkins University, speaks with MedPage Today's Director of Video Greg Laub, to discuss the lessons that the he...

Respiratory Therapists Play Critical Role in COVID-19 Pandemic
https://www.medpagetoday.com/infectiousdisease/covid19/86302

May 4th, 2020 - On her first night as a visiting respiratory therapist in the Bronx, Shera McClelland, RRT, was overwhelmed by the number of COVID-19 patients she saw in critical care. "I walked in and I immediately was struck with emotion," said McClelland, who ...

Risks of removing the default: Lung protective ventilation IS for everyone
https://www.mdedge.com/chestphysician/article/196672/critical-care/risks-removing-default-lung-protective-ventilation?channel=28399
Kusum S. Mathews, MD, MPH, MSCR, And Daniel Howell, MBBS Msc

Apr 9th, 2019 - Since the landmark ARMA trial, use of low tidal volume ventilation (LTVV) at 6 mL/kg predicted body weight (PBW) has become our gold standard for ventilator management in acute respiratory distress syndrome (ARDS) (Brower RG, et al. N Engl J Med.

Risks of removing the default: Lung protective ventilation IS for everyone
https://www.mdedge.com/chestphysician/article/196672/critical-care/risks-removing-default-lung-protective-ventilation
Kusum S. Mathews, MD, MPH, MSCR, And Daniel Howell, MBBS Msc

Apr 9th, 2019 - Since the landmark ARMA trial, use of low tidal volume ventilation (LTVV) at 6 mL/kg predicted body weight (PBW) has become our gold standard for ventilator management in acute respiratory distress syndrome (ARDS) (Brower RG, et al. N Engl J Med.

see more →